1. β-Catenin Links von Hippel-Lindau to Aurora Kinase A and Loss of Primary Cilia in Renal Cell Carcinoma
   Ruhee Dere et al, 2015, Journal of the American Society of Nephrology CrossRef
2. Regulation of cell cycle by MDM2 in prostate cancer cells through Aurora Kinase-B and p21WAF1/CIP1 mediated pathways
   Thanigaivelan Kanagasabai et al, 2020, Cellular Signalling CrossRef
3. A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle
   Hong-Li Li et al, 2023, Molecules CrossRef
4. The molecular mechanisms of a novel multi-kinase inhibitor ZLJ33 in suppressing pancreatic cancer growth
   Yan Li et al, 2015, Cancer Letters CrossRef
5. RNA interference-mediated knockdown of Aurora-B alters the metastatic behavior of A549 cells via modulation of the phosphoinositide 3-kinase/Akt signaling pathway
   LONG DIAN ZHOU et al, 2014, Oncology Letters CrossRef
6. Research Progress on the Hypoglycemic Effects and Mechanisms of Action of Momordica charantia polysaccharide
   Jinshen Liu et al, 2023, Journal of Food Biochemistry CrossRef
7. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma
   Zachary A. Glaser et al, 2017, Urologic Oncology: Seminars and Original Investigations CrossRef
8. Knockdown of Aurora-B inhibits the growth of non-small cell lung cancer A549 cells
   JING JING YU et al, 2015, Oncology Letters CrossRef
9. RNA-seq Reveals Aurora Kinase–Driven mTOR Pathway Activation in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma
   Sumanta K. Pal et al, 2015, Molecular Cancer Research CrossRef
10. Silver‐Catalyzed para‐Selective Sulfenyl Group Transfer Reactions of N‐Sulfenylanilides
    Itaru Nakamura et al, 2023, Chemistry – A European Journal CrossRef
11. PP6 Controls T Cell Development and Homeostasis by Negatively Regulating Distal TCR Signaling
    Jian Ye et al, 2015, The Journal of Immunology CrossRef
12. Silencing Aurora A leads to re-sensitization of breast cancer cells to Taxol through downregulation of SRC-mediated ERK and mTOR pathways
    Yan Li et al, 2017, Oncology Reports CrossRef
13. 4-[(5-Methyl-1H-pyrazol-3-yl)amino]-2H-phenyl-1-phthalazinone Inhibits MCPyV T Antigen Expression in Merkel Cell Carcinoma Independent of Aurora Kinase A
    Roland Houben et al, 2023, Cancers CrossRef
14. Synthesis and biological evaluation of 2,4-disubstituted phthalazinones as Aurora kinase inhibitors
    Wei Wang et al, 2018, Bioorganic & Medicinal Chemistry CrossRef
15. Differences in gene expression and alterations in cell cycle of acute myeloid leukemia cell lines after treatment with JAK inhibitors
    Pawel Gunerka et al, 2015, European Journal of Pharmacology CrossRef
16. KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway
    Meng Zhai et al, 2024, Journal of Cancer Research and Clinical Oncology CrossRef
17. Inhibition of Aurora-B suppresses osteosarcoma cell migration and invasion
    XIAO PING ZHU et al, 2014, Experimental and Therapeutic Medicine CrossRef
18. Clinical outcome of treatment with serine-threonine kinase inhibitors in recurrent epithelial ovarian cancer: a systematic review of literature
    Marcia A. Ciccone et al, 2016, Expert Opinion on Investigational Drugs CrossRef
19. The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review
    Kai Liu et al, 2020, Cancer Cell International CrossRef
20. RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)
    Sofie Martens et al, 2018, Cell Death & Disease CrossRef
21. Molecular Genetics of Renal Cell Carcinoma
    Tomoya Fukawa et al, 2017, Renal Cell Carcinoma CrossRef
22. AURKB promotes immunogenicity and immune infiltration in clear cell renal cell carcinoma
    Weihao Liu et al, 2024, Discover Oncology CrossRef
23. Quantifying critical states of complex diseases using single-sample dynamic network biomarkers
    Xiaoping Liu et al, 2017, PLOS Computational Biology CrossRef
24. Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinoma
    Matteo Santoni et al, 2014, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
25. VHL loss predicts response to Aurora kinase A inhibitor in renal cell carcinoma cells
    Xiao‑Fei Ding et al, 2018, Molecular Medicine Reports CrossRef
26. mTOR Pathway in Renal Cell Carcinoma
    Matteo Santoni et al, 2016, Molecules to Medicine with mTOR CrossRef